Shuttleworth; Stephen Joseph
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shuttleworth; Stephen Joseph.The latest application filed is for "tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors".
Company Profile
13.27.32
- Shuttleworth; Stephen Joseph - Oxfordshire GB
- Shuttleworth; Stephen Joseph - Abingdon GB
- Shuttleworth; Stephen Joseph - Southampton GB
- Shuttleworth; Stephen Joseph - Hampshire GB
- Shuttleworth; Stephen Joseph - Slough N/A GB
- Shuttleworth; Stephen Joseph - Berkshire GB
- Shuttleworth; Stephen Joseph - Foster City CA
- Shuttleworth; Stephen Joseph - San Francisco CA
- Shuttleworth, Stephen Joseph - South San Francisco CA
Patent Activity
| Patent | Date |
|---|---|
| Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent Grant 11,291,669 - Shuttleworth , et al. April 5, 2 | 2022-04-05 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20220041624 - Shuttleworth; Stephen Joseph ; et al. | 2022-02-10 |
| Compounds Comprising Tricyclic Heterocyclic Compounds App 20210275537 - Shuttleworth; Stephen Joseph ; et al. | 2021-09-09 |
| Compositions Comprising Phosphoinositide 3-kinase Inhibitors And A Second Antiproliferative Agent App 20210069200 - Shuttleworth; Stephen Joseph ; et al. | 2021-03-11 |
| Oxadiazolylthiophene Derivatives Useful As Histone Deacetylase Inhibitors App 20210038607 - Shuttleworth; Stephen Joseph ; et al. | 2021-02-11 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20200354378 - Shuttleworth; Stephen Joseph ; et al. | 2020-11-12 |
| Combinations Comprising Histone Deacetylase Inhibitors App 20200316062 - Shuttleworth; Stephen Joseph ; et al. | 2020-10-08 |
| Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent Grant 10,668,077 - Shuttleworth , et al. | 2020-06-02 |
| Polyheteroarl histone deacetylase inhibitors and their use in therapy Grant 10,533,003 - Shuttleworth , et al. Ja | 2020-01-14 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 10,513,530 - Shuttleworth , et al. Dec | 2019-12-24 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 10,501,478 - Shuttleworth , et al. Dec | 2019-12-10 |
| Diheteroaryl histone deacetylase inhibitors and their use in therapy Grant 10,407,435 - Shuttleworth , et al. Sept | 2019-09-10 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 10,377,764 - Shuttleworth , et al. A | 2019-08-13 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20190092790 - Shuttleworth; Stephen Joseph ; et al. | 2019-03-28 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20190040079 - Shuttleworth; Stephen Joseph ; et al. | 2019-02-07 |
| Compositions Comprising Phosphoinositide 3-kinase Inhibitors And A Second Antiproliferative Agent App 20180243313 - Shuttleworth; Stephen Joseph ; et al. | 2018-08-30 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20180244686 - Shuttleworth; Stephen Joseph ; et al. | 2018-08-30 |
| Compounds Comprising Tricyclic Heterocyclic Compounds App 20180235974 - Shuttleworth; Stephen Joseph ; et al. | 2018-08-23 |
| Phosphoinositide 3-kinase inhibitors Grant 10,035,785 - Shuttleworth , et al. July 31, 2 | 2018-07-31 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 9,981,987 - Shuttleworth , et al. May 29, 2 | 2018-05-29 |
| Phosphoinositide 3-kinase Inhibitors App 20180072699 - Shuttleworth; Stephen Joseph ; et al. | 2018-03-15 |
| Polyheteroarl Histone Deacetylase Inhibitors And Their Use In Therapy App 20170313698 - Shuttleworth; Stephen Joseph ; et al. | 2017-11-02 |
| Diheteroaryl Histone Deacetylase Inhibitors And Their Use In Therapy App 20170313712 - Shuttleworth; Stephen Joseph ; et al. | 2017-11-02 |
| Phosphoinositide 3-kinase inhibitors Grant 9,663,487 - Shuttleworth , et al. May 30, 2 | 2017-05-30 |
| Tricyclic Heterocyclic Compounds As Phosphoinositide 3-kinase Inhibitors App 20160347771 - Shuttleworth; Stephen Joseph ; et al. | 2016-12-01 |
| Scriptaid isosteres and their use in therapy Grant 9,340,503 - Shuttleworth , et al. May 17, 2 | 2016-05-17 |
| Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease Grant 9,266,879 - Shuttleworth , et al. February 23, 2 | 2016-02-23 |
| Novel Histone Deacetylase Inhibitors And Their Use In Therapy App 20150361074 - Shuttleworth; Stephen Joseph ; et al. | 2015-12-17 |
| Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors Grant 9,200,007 - Shuttleworth , et al. December 1, 2 | 2015-12-01 |
| Phosphoinositide 3-kinase Inhibitors App 20150080395 - Shuttleworth; Stephen Joseph ; et al. | 2015-03-19 |
| Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors Grant 8,981,087 - Shuttleworth , et al. March 17, 2 | 2015-03-17 |
| Scriptaid Isosteres And Their Use In Therapy App 20140235671 - SHUTTLEWORTH; Stephen Joseph ; et al. | 2014-08-21 |
| Scriptaid isosteres and their use in therapy Grant 8,748,458 - Shuttleworth , et al. June 10, 2 | 2014-06-10 |
| Pharmaceutical compounds Grant 8,697,693 - Baker , et al. April 15, 2 | 2014-04-15 |
| Depsipeptides and their therapeutic use Grant 8,614,193 - Shuttleworth , et al. December 24, 2 | 2013-12-24 |
| Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease App 20130109688 - Shuttleworth; Stephen Joseph ; et al. | 2013-05-02 |
| Pharmaceutical Compounds App 20120283257 - Baker; Stewart James ; et al. | 2012-11-08 |
| Pyrimidine derivatives as PI3K inhibitors Grant 8,252,792 - Baker , et al. August 28, 2 | 2012-08-28 |
| Tricyclic Heterocyclic Compounds as Phosphoinositide 3-Kinase Inhibitors App 20120178737 - Shuttleworth; Stephen Joseph ; et al. | 2012-07-12 |
| Benzo [E] [1,3] Oxazin-4-One Derivatives as Phosphoinositide 3-Kinase Inhibitors App 20120129848 - Shuttleworth; Stephen Joseph ; et al. | 2012-05-24 |
| Scriptaid Isosteres and Their Use in Therapy App 20110305729 - Shuttleworth; Stephen Joseph ; et al. | 2011-12-15 |
| Depsipeptides and Their Therapeutic Use App 20110112090 - Shuttleworth; Stephen Joseph ; et al. | 2011-05-12 |
| Pharmaceutical Compounds App 20100256143 - Baker; Stewart James ; et al. | 2010-10-07 |
| 2-morpholin-4-yl-pyrimidines As Pi3k Inhibitors App 20100210646 - Goldsmith; Paul John ; et al. | 2010-08-19 |
| Pyrimidine Derivatives As Inhibitors Of Phosphatidylinositol-3-kinase App 20100130496 - Goldsmith; Paul John ; et al. | 2010-05-27 |
| Pyrimidine Derivatives As Pi3k Inhibitors App 20100016306 - Baker; Stewart James ; et al. | 2010-01-21 |
| Fused heterocyclic compounds Grant 7,125,885 - Chen , et al. October 24, 2 | 2006-10-24 |
| Fused heterocyclic compounds App 20050148617 - Chen, Xiaoqi ; et al. | 2005-07-07 |
| Compounds and methods for the treatment or prevention of Flavivirus infections Grant 6,887,877 - Chan Chun Kong , et al. May 3, 2 | 2005-05-03 |
| Fused heterocyclic compounds Grant 6,809,104 - Chen , et al. October 26, 2 | 2004-10-26 |
| Compounds and methods for the treatment or prevention of flavivirus infections App 20030229053 - Chan Chun Kong, Laval ; et al. | 2003-12-11 |
| Fused heterocyclic compounds App 20030176694 - Chen, Xiaoqi ; et al. | 2003-09-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 